Quick Details
- Processing Time:-
- Port:-
- Supply Ability: -
- Brand Name:HOSPITECH
Cancer Diagnostic Probe (CDP) is a real-time diagnostic system used as a complementary tool, along with Frozen and Permanent pathologies, to detect high risk cancer cells in the internal margins
(cavity side margins) of patients undergoing breast cancer surgery. CDP detects hypoxia glycolysis immediately and quantitatively. This system with US patent ID (Pub. No: US 2018/0299401 A1, Pub.
Date: Oct 18, 2018), License No: 23212882 has been introduces as a surgical assistant system in breast cancer surgery. CDP reveals the cancerous cells in the internal margins (cavity –side
margin) within a few millimeters in 40 seconds, using a needle sensor, and has a clinical diagnostic classification matching with the pathological results of the tested tissues.
